Navigation Links
Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
Date:9/4/2007

The largest-ever study of treatments for type 2 diabetes has shown that a combination of two blood pressure lowering drugs reduced the risk of death, as well as the risks of heart and kidney disease. The ADVANCE (Action in Diabetes and Vascular Disease) Study was led by researchers at The George Institute for International Health in Sydney and the results have been presented at the European Congress of Cardiology in Vienna.

One of the study leaders, Professor Stephen MacMahon, Principal Director of The George Institute, said "These results represent an important step forward in the care of people with type 2 diabetes worldwide. This treatment reduced the likelihood of dying from the complications of diabetes by almost one-fifth, and could potentially save several millions of lives over the next decade if the treatment was widely implemented.

More than 600,000 Australians and more than 250 million people worldwide have type 2 diabetes, and most will eventually die or be disabled by the complications. The most common cause of death is heart disease, but kidney disease also affects a large proportion. In 2006, the United Nations called for increased international action to combat the global epidemic of diabetes.

More than 11,000 patients with type 2 diabetes in 20 countries world wide participated in the 4.3 year project. Half received daily treatment with a single tablet containing a fixed combination of two blood pressure lowering drugs (perindopril plus indapamide) and half received matching inactive placebo.

Importantly, the ADVANCE results showed that patients with type 2 diabetes benefited from this blood pressure lowering treatment irrespective of whether or not their blood pressure was elevated to begin with, said study investigator, Dr Bruce Neal, of The George Institute,

The participants in ADVANCE were already receiving most of the usual treatments provided to patients with diabetes, including other drugs to
'/>"/>

Contact: Janet Hall
janethall@bigpond.com
61-411-187-808
Research Australia
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. International community warns India on HIV situation
2. Key step forward on International Health Rules
3. ICMR along with other International Research organisation with drug development for Neglected Diseases
4. International Osteoporosis Research Centre To Be Started In India.
5. Indian hospitals require International Accreditation
6. International Conference On Malaria - Laveran To Genomics
7. Delhi To Host International Women’s Congress From Nov 2
8. International conference on Ayurveda to be held on Kerala
9. International Teleradiology: The Future Of Radiologic Diagnosis
10. John Mendelsohn M.D, chosen for an International Award
11. Thailand To Procure Botulism Antitoxin Internationally

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... A jury of 8 people in the Western Distri...,300,000 in pain and suffering for a medical malpr...man and Alicia Nocera of Thomas E. Crenney and Ass...intiff, Vita Monestersky and against the Uniontown...al abdominal hysterectomy at age 18. , ...
(Date:11/8/2009)..., Nov. 8 Pharmaceutical...ior Vice President Ken Johnson released the follow...rm bill: ,, "We are disappointed, but not surpr...llions of hardworking Americans as well as nearly ...atives who voted against the bill. ,, "While we...
(Date:11/8/2009)...ses House Passage of Health Care Reform Bill ,... improve coverage for all Americans ,, BALTIMO...onight the United States House of Representatives ...t would strengthen Medicare for seniors and end di...llions of Americans out of affordable health cover...
(Date:11/7/2009)...ov. 7 The American Medi..., Director of Health at the Family Violence Preven...vice today at its semi-annual policy-making meetin...highest honor the AMA House of Delegates bestows o...wscom.com/cgi-bin/prnh/20081209/AMALOGO ) ,, ...
(Date:11/7/2009)...Faithful Catholics have a responsibility to vigoro...the status quo." ,, WASHINGTON, Nov. 7 /PRN...dent Judie Brown released the following statement ...rt Speaker Nancy Pelosi,s Affordable Health Care f...preserving the status quo for abortion is voted up...
Breaking Medicine News(10 mins):Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors Family Violence Prevention Expert 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2
...est working hours in Europe - a reason that is dri...says a study //. Stress expert Cary Cooper, o... of work seem to be having their negative effect o...udied 2,200 men and found that 37 percent of them ...
... be now treated by a new approach involving releas... made with mice by scientists // at John Hopkins I...-Nathans Institute for Genetic Medicine. The d...called GCN5 is critical for controlling a domino-l...
...BP medication during first trimester of pregnancy ...abies - The Food and Drug Administration reports f...University Medical Center. The study, led by W...rs who took angiotensin converting enzyme inhibito...
...sthan man who has pledged not to marry till he pas...ger for a wife. He has failed in the examination y...ident of Kohari village of Behror town, over 140 k...condary examinations. But he has consistently fail...
...at the COX enzymes interact physically in a bioche...opment of blood vessels. // The study was cond...ania School of Medicine and Queen's University, On...ogy. Collaborators Garret FitzGerald, MD, Directo...
...re made in heaven, they say. But what about homose...omosexuality has been on top //of the flak-charts ...s are only getting stronger against gay and lesbia...is national question requires a national solution,...
Other Medicine News:Health News:Diabetes - New Treatment Approach At John Hopkins 2Health News:Birth Defects Link With ACE Inhibitor Use, FDA Reports 2Health News:New Role of COX Enzymes Discovered 2Health News:Differently Wired and Gay – Are They Children of a Lesser God 2
(Date:11/6/2009)...ire/ -- , - Trial Will Compare NXL103 Wit...f Multi-Resistant Staphylococcus Aureus (MRSA) Inf...tical company focused on the discovery and,develop... significant global,problem of microbial resistanc...ibacterial NXL103 (flopristin/linopristin), has st...
(Date:11/5/2009)... Transcept Pharmaceutica...cal company focused on the development and commerc...portant therapeutic needs in the field of neurosci...eleconference with management to discuss third qua...12, 2009, at 5:00 p.m. Eastern Standard Time. Fin...
(Date:11/5/2009)...ewswire/ -- Renee Cobos, MD, a board certified der...at the University of California, Irvine, announced...us results with Thermage CPT®. The updated sy...ntouring, features a new vibrating hand piece that... comfort. ,, "Thermage has always been popular...
Breaking Medicine Technology:Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R) 2Good news for some hard to treat hepatitis C patients 49004 1Good news for some hard to treat hepatitis C patients 49004 2MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE a Global Phase 2 3 Clinical Trial of Teplizumab in Type 1 Diabetes 4596 1MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE a Global Phase 2 3 Clinical Trial of Teplizumab in Type 1 Diabetes 4596 2MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE a Global Phase 2 3 Clinical Trial of Teplizumab in Type 1 Diabetes 4596 3MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE a Global Phase 2 3 Clinical Trial of Teplizumab in Type 1 Diabetes 4596 4A Power Energy Generation Systems Ltd Signs a Biomass Based DG Contract with Sanmenxia New Energy Bio Electricity Co Ltd 12639 1A Power Energy Generation Systems Ltd Signs a Biomass Based DG Contract with Sanmenxia New Energy Bio Electricity Co Ltd 12639 2A Power Energy Generation Systems Ltd Signs a Biomass Based DG Contract with Sanmenxia New Energy Bio Electricity Co Ltd 12639 3
...estive Disease Week data highlight effects of AMIT...C, SAN DIEGO, May 18 New study results indicated...cg lead to significant relief,of overall symptoms ...-C).,These results were presented at Digestive Dis...onal meeting of digestive disease specialists., "...
... that Adding Singulair to Advair Offers no Additio...Control, RESEARCH TRIANGLE PARK, N.C. and TORONTO...oth asthma and allergic rhinitis, or seasonal alle...n when treated with Advair,Diskus(R) (fluticasone ...mpared with Singulair (montelukast sodium). The re...
Other Medicine Technology:New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C) 2New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C) 3New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C) 4New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C) 5New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C) 6New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C) 7Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM) 2Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM) 3
...dth of infectious disease ELISA products make us a...ls for faster integration into the busy laboratory...creased reliability and run-to-run consistency. Ou...detection assays for a wide range of serological a...
...dth of infectious disease ELISA products make us a...ls for faster integration into the busy laboratory...creased reliability and run-to-run consistency. Ou...detection assays for a wide range of serological a...
...dth of infectious disease ELISA products make us a...ls for faster integration into the busy laboratory...creased reliability and run-to-run consistency. Ou...detection assays for a wide range of serological a...
...dth of infectious disease ELISA products make us a...ls for faster integration into the busy laboratory...creased reliability and run-to-run consistency. Ou...detection assays for a wide range of serological a...
Medicine Products: